<?xml version="1.0" encoding="UTF-8" ?>
<protolog id="rid.8224_nm.10944" type="emendation" xmlns="http://namesforlife.com/ns/protolog" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://namesforlife.com/ns/protolog file:/C:/NamesforLife/workspace/namesforlife-schema/protolog.xsd"><organism doi="10.1601/nm.10944" exemplar-doi="10.1601/ex.10944" rank="species">Phaeobacter daeponensis</organism><reference id="rid.8224"><citation citation-type="journal"><authors><person-name><surname>Vandecandelaere</surname><given-names>I.</given-names></person-name><person-name><surname>Segaert</surname><given-names>E.</given-names></person-name><person-name><surname>Mollica</surname><given-names>A.</given-names></person-name><person-name><surname>Faimali</surname><given-names>M.</given-names></person-name><person-name><surname>Vandamme</surname><given-names>P.</given-names></person-name></authors><article-title>Leisingera aquimarina sp. nov., isolated from a marine electroactive biofilm, and emended descriptions of Leisingera methylohalidivorans Schaefer et al. 2002, Phaeobacter daeponensis Yoon et al. 2007 and Phaeobacter inhibens Martens et al. 2006.</article-title><year>2008</year><volume>58</volume><issue>12</issue><fpage>2788</fpage><lpage>2793</lpage><source id="117">International Journal of Systematic and Evolutionary Microbiology</source><abbrev>Int J Syst Evol Microbiol</abbrev><issn>1466-5026</issn><essn>1466-5034</essn><pub-id pub-id-type="doi">10.1099/ijs.0.65844-0</pub-id><pub-id pub-id-type="pmid">19060059</pub-id></citation></reference><content><p class="title"><s>Emended description of <em>Phaeobacter daeponensis</em> Yoon <em>et al.</em> 2007</s></p><p class="etymology" /><p class="description"><s>The description is as given by Yoon <em>et al.</em> (2007) with the following additions.</s><s>Grows weakly on TSA and NA; does not grow on PYG or R2A.</s><s>Does not hydrolyse DNA.</s><s>No fermentation of glucose.</s><s>No activity is detected for urease.</s><s>Susceptible to cefoxitin (30 μg) and vancomycin (30 μg).</s><s>Intermediately susceptible to erythromycin (15 μg).</s><s>Resistant to trimethoprim (1.25 μg) and clindamycin (2 μg).</s></p></content></protolog>